April 18 (Reuters) - Adocia SA ADOC.PA :
* Cash position of 52 million euros ($55.34 million) at
March 31, 2017
* Q1 revenue 19.4 million euros versus 6.8 million euros
year ago
* Expects in next few months to receive reimbursement of
research and tax credit for 2016 expenses that should favorably
impact its cash position by 7.8 million euros
* Preparing a dose-response study in people with type 1
diabetes, which should start during second quarter of 2017
* Regarding biochaperone combo, expects results of ongoing
clinical study phase 1/2 monitoring postprandial glycemic
control in people with type 2 diabetes in Q2 2017
Source text for Eikon: ID:nBw5f4BQma
Further company coverage: ADOC.PA
($1 = 0.9397 euros)
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))